Requires insurance companies and medical assistance programs to cover prescribed antiviral COVID-19 treatments at no cost to patients.

New York S10136 amends the insurance law to mandate that insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations, and medical assistance programs cover antiviral therapeutics approved by the FDA for COVID-19 treatment at no cost to patients. This coverage applies to policies and contracts providing prescription drug coverage, with no annual deductibles or coinsurance. Patients eligible for free or reduced-cost treatments through manufacturers or government programs may be required to use those programs first.

Requires insurance companies and medical assistance programs to cover prescribed antiviral COVID-19 treatments at no cost to patients.

New York S10136 amends the insurance law to mandate that insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations, and medical assistance programs cover antiviral therapeutics approved by the FDA for COVID-19 treatment at no cost to patients. This coverage applies to policies and contracts providing prescription drug coverage, with no annual deductibles or coinsurance. Patients eligible for free or reduced-cost treatments through manufacturers or government programs may be required to use those programs first.